Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
INFLECTRA Trockensub 100 mg Durchstf
Drug
Inflectra, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Rheumatoide Arthritis; Psoriatische Arthritis; Morbus Crohn; Morbus Bechterew; aktive ulcerative Colitis; Plaque-Psoriasis
07.15.0. – immunosuppressants
HAM – Human medicine
PULPA – Powder for parenteral solution
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
10/9/2015
12/31/9999
Dosage strength
Inflectra 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Rheumatoide Arthritis; Psoriatische Arthritis; Morbus Crohn; Morbus Bechterew; aktive ulcerative Colitis; Plaque-Psoriasis
01
Z – approved
Package
7680653670015
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component Freeze-dried preparation
100 mg infliximabum
saccharum
natrii dihydrogenophosphas monohydricus
dinatrii phosphas dihydricus
polysorbatum 80
2.0 mg natrium
natrii dihydrogenophosphas monohydricus
dinatrii phosphas dihydricus
polysorbatum 80
2.0 mg natrium
Spezialitätenliste***
SL
-
-
586.15
None
Yes
10%
No
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
5/1/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.